Ovid Therapeutics announced the promotion of Meg Alexander to President and Chief Operating Officer, COO. Alexander will work in collaboration with Ovid‘s leadership team to advance Ovid’s development pipeline of potential disease-halting neurotherapeutics and define and execute its go-forward strategy.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OVID: